In order to verify the results, we analyzed disease-free survival of breast cancer patients according to HER2 status at the same time (see Supplementary Fig. S2) and the results of the analysis show the same trend as before that lncRNA00544 expression is correlated with prognosis in patients with HER2− HR+ breast cancer. The gene discussed is ERBB2; the disease is breast carcinoma.